التفاصيل البيبلوغرافية
| العنوان: |
Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infections. |
| المؤلفون: |
Sayan, Murat, Özgüler, Müge, Yıldırı, Figen Sarıgül, Yıldırmak, Taner, Gündüz, Alper, Dokuzoğuz, Başak, Çelen, Mustafa Kemal, İnan, Dilara, Heper, Yasemin, Ersöz, Gülden, Karaoğlan, İlkay, Ceran, Nurgül, Deveci, Aydın, Öztürk, Servet, Kutlu, Selda Sayın, Özdemir, Hülya Özkan, Akbulut, Ayhan, Yazıcı, Saadet, Şener, Alper, Çağatay, Atahan |
| المصدر: |
Balkan Medical Journal; May2020, Vol. 37 Issue 3, p125-130, 6p |
| مصطلحات موضوعية: |
HEPATITIS C risk factors, HIV infection epidemiology, DRUG resistance in microorganisms, ENZYME-linked immunosorbent assay, HEPATITIS B, MOLECULAR epidemiology, GENETIC mutation, POLYMERASE chain reaction, WESTERN immunoblotting, CROSS-sectional method, RETROSPECTIVE studies, MIXED infections, DISEASE risk factors |
| مصطلحات جغرافية: |
TURKEY |
| مستخلص: |
Background: Because of their similar modes of transmission, the simultaneous infection of viral hepatitis and human immunodeficiency virus are increasingly seen as a big problem related to human health. Aims: To determine the drug mutations in hepatitis B virus and/ or hepatitis C virus co-infected human immunodeficiency virus-1 patients in Turkey. Study Design: Retrospective cross-sectional study. Methods: The present study was conducted between 2010 and 2017. HBsAg, anti-hepatitis C virus, and anti-human immunodeficiency virus were tested with ELISA. All anti-human immunodeficiency virus positive results by ELISA were verified for anti-human immunodeficiency virus positivity by a Western blot test, and Antihuman immunodeficiency virus positive patients with HBsAg and/or anti-hepatitis C virus positivity were included in the study. Subtyping and genotypic resistance analyses were performed by population sequencing of the viral protease and reverse transcriptase regions of the human immunodeficiency virus-1 pol gene. Results: We detected 3896 human immunodeficiency virus-1 positive patients whose sera were sent from numerous hospitals across the country to our polymerase chain reaction unit for detection of drug resistance mutations and whose molecular laboratory tests were completed. Viral hepatitis co-infections were detected in 4.3% (n=170) of patients. Hepatitis B virus and hepatitis C virus co-infection were observed in 3.2% and 0.5% of all human immunodeficiency virus-1 infected patients, respectively. The major human immunodeficiency virus-1 subtype detected was group M, subtype B (62.9%). However, 13.5% of drug resistance mutation motifs were found in human immunodeficiency virus-1 genomes of patients included in the study. Conclusion: Due to similar transmission routes, HIV1 patients are at risk of hepatitis B and C virus co-infection. However, antiretroviral drug resistance mutation model is similar to patients with hepatitis negative. [ABSTRACT FROM AUTHOR] |
|
Copyright of Balkan Medical Journal is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder